Dr Komrokji on the Importance of Establishing a Clinical Consensus Regarding the Use of Molecular Testing in MDS

Rami Komrokji, MD, vice chair, Malignant Hematology Department, Moffitt Cancer Center, discusses the role of molecular testing in myelodysplastic syndromes (MDS) and the importance of establishing a clinical consensus to standardize its use in routine practice. These considerations were highlighted in a discussion at the Bridging The Gaps: Leukemia, Lymphoma, and Multiple Myeloma in Miami, Florida.